MDxHealth SA logo

MDXH - MDxHealth SA Share Price

€1.17 0.0  0.9%

Last Trade - 12:14pm

Sector
Healthcare
Size
Small Cap
Market Cap £108.5m
Enterprise Value £99.2m
Revenue £7.80m
Position in Universe 497th / 847
Bullish
Bearish
Unlock MDXH Revenue
Momentum
Relative Strength (%)
1m -1.31%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -6.46%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
11.7 17.6 30.0 40.5 28.4 11.8 21.0 27.7 +0.2%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, MDxHealth SArevenues decreased 9% to $9.9M. Net loss decreased 3% to$13.7M. Revenues reflect United States of America segmentdecrease of 8% to $9.6M, Rest of EU segment decrease of 26%to $162K. Lower net loss reflects General andadministrative expenses decrease of 57% to $7.3M (expense),Other Operating Income increase from $9K to $59K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MDXH Revenue Unlock MDXH Revenue

Net Income

MDXH Net Income Unlock MDXH Revenue

Normalised EPS

MDXH Normalised EPS Unlock MDXH Revenue

PE Ratio Range

MDXH PE Ratio Range Unlock MDXH Revenue

Dividend Yield Range

MDXH Dividend Yield Range Unlock MDXH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MDXH EPS Forecasts Unlock MDXH Revenue
Profile Summary

MDxHealth SA is a Belgium-based multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated January 15, 2003
Public Since June 28, 2006
No. of Shareholders: n/a
No. of Employees: 177
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Euronext - Brussels
Shares in Issue 108,829,737
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MDXH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MDXH
Upcoming Events for MDXH
Frequently Asked Questions for MDxHealth SA
What is the MDxHealth SA share price?

As of 12:14pm, shares in MDxHealth SA are trading at €1.17, giving the company a market capitalisation of £108.5m. This share price information is delayed by 15 minutes.

How has the MDxHealth SA share price performed this year?

Shares in MDxHealth SA are currently trading at €1.17 and the price has moved by 41.05% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the MDxHealth SA price has moved by 27.35% over the past year.

What are the analyst and broker recommendations for MDxHealth SA?

Of the analysts with advisory recommendations for MDxHealth SA, there are there are currently 3 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for MDxHealth SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will MDxHealth SA next release its financial results?

MDxHealth SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the MDxHealth SA dividend yield?

MDxHealth SA does not currently pay a dividend.

Does MDxHealth SA pay a dividend?

MDxHealth SA does not currently pay a dividend.

When does MDxHealth SA next pay dividends?

MDxHealth SA does not currently pay a dividend.

How do I buy MDxHealth SA shares?

To buy shares in MDxHealth SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of MDxHealth SA?

Shares in MDxHealth SA are currently trading at €1.17, giving the company a market capitalisation of £108.5m.

Where are MDxHealth SA shares listed? Where are MDxHealth SA shares listed?

Here are the trading details for MDxHealth SA:

Country of listing: Belgium
Exchange: BRU
Ticker Symbol: MDXH
What kind of share is MDxHealth SA?

Based on an overall assessment of its quality, value and momentum, MDxHealth SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a MDxHealth SA share price forecast 2021?

Shares in MDxHealth SA are currently priced at €1.17. At that level they are trading at 2.9% discount to the analyst consensus target price of 0.00.

Analysts covering MDxHealth SA currently have a consensus Earnings Per Share (EPS) forecast of -0.379 for the next financial year.

How can I tell whether the MDxHealth SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MDxHealth SA. Over the past six months, the relative strength of its shares against the market has been 46.59%. At the current price of €1.17, shares in MDxHealth SA are trading at 37% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the MDxHealth SA PE Ratio?

We were not able to find PE ratio data for MDxHealth SA.

Who are the key directors of MDxHealth SA?

MDxHealth SA's management team is headed by:

Joseph Sollee - EVP
Christopher Thibodeau - EVP
Rudi Marien - NED
Ruth Devenyns - NID
Jan Pensaert - NED
Walter Narajowski - NID
Mark Shaffar - NEC
Michael McGarrity - CEO
John Bellano - OTH
Ron Kalfus - CFO
Who are the major shareholders of MDxHealth SA?

Here are the top five shareholders of MDxHealth SA based on the size of their shareholding:

MVM Partners LLP Venture Capital
Percentage owned: 18.53% (20.2m shares)
Valiance Advisors LLP Investment Advisor/Hedge Fund
Percentage owned: 10.25% (11.2m shares)
Marien (Rudi) Individual Investor
Percentage owned: 10.19% (11.1m shares)
Soleus Capital Management, L.P. Hedge Fund
Percentage owned: 5.79% (6.30m shares)
Versluys (Bart) Individual Investor
Percentage owned: 3.55% (3.87m shares)
Similar to MDXH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.